Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 24Terminated 9Recruiting 9Active not recruiting 7Withdrawn 2Unknown 2Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Recurrence 1Neuroblastoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Extranodal NK-T-Cell 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

blinatumomab 10Cyclophosphamide 6fludarabine 4Vincristine 4Methotrexate 4Dexamethasone 4Cytarabine 4venetoclax 3Whole-Body Irradiation 2Thiotepa 2Therapeutics 2Mercaptopurine 2Exercise 2Busulfan 2ruxolitinib 1revumenib 1ponatinib 1pegaspargase 1olverembatinib 1navitoclax 1fludarabine phosphate 1etoposide phosphate 1capivasertib 1asciminib 1Ultrasonography 1Transplantation 1Prednisolone 1Melphalan 1Levofloxacin 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Thiotepa × Clear all
NCT07565220 2026-05-04

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

University of Pittsburgh

Phase 1 Not yet recruiting
48 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05565105 2026-03-03

CD34+ Transplants for Leukemia and Lymphoma

Baptist Health South Florida

Phase 2 Not yet recruiting
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡